Author: openjargon

  • Bell Potter says these ASX 200 shares can deliver ~30% returns

    If you’re on the hunt for some big returns for your portfolio, then you may want to check out these ASX 200 shares in this article.

    That’s because Bell Potter has named them as buys and is tipping them to deliver mouth-watering returns over the next 12 months. Here’s what the broker is saying about them:

    Amotiv Ltd (ASX: AOV)

    Bell Potter remains very positive on Amotiv, which was until recently known as GUD Holdings.

    It is a consumer and industrial products company primarily focusing on automotive aftermarket parts and accessories. For automotive aftermarket products, its brands include Ryco, Wesfil, Goss, Brown and Watson. And for 4WD accessories, it operates under the APG brand.

    Bell Potter likes this ASX 200 share due to its undemanding valuation and positive outlook. It explains:

    We are Buy-rated on Amotiv and consider it to be fundamentally a good business and we note upside may exist from APG’s geographic expansion which is not in our earnings forecasts. The legacy auto business has been reasonably strong to date in an environment where there is increased risk around service trade down and deferral. The stock’s valuation is not demanding at 13x FY25 PE. Overall, our Buy rating for AOV is predicated on the relative resilience of the legacy auto business and improving momentum in new car sales, which should be favourable for APG’s earnings.

    The broker currently has a buy rating and $12.80 price target on its shares. This implies potential upside of almost 27% for investors. The total return stretches to 30% including dividends.

    Capricorn Metals Ltd (ASX: CMM)

    Another ASX 200 share that could offer big returns is Capricorn Metals. It is a gold exploration and development company whose primary asset its 100%-owned Karlawinda Gold Project (KGP) in Western Australia.

    Bell Potter has been very impressed with the quality of the KGP operation and management’s strong track record. It explains:

    CMM’s management team has a track record of capital efficient project funding, development, commissioning and operation. In our view, FY25 and FY26 should benefit from higher revenue and EPS increases by 32% and 6% respectively. CMM is a sector leading gold producer with a strong balance sheet, a management team with an excellent track record of delivery and clear organic growth options to lift group production to 270kozpa.

    The broker currently has a buy rating and $6.53 price target on its shares. This suggests that its shares could rise almost 30% from current levels.

    The post Bell Potter says these ASX 200 shares can deliver ~30% returns appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Capricorn Metals Ltd right now?

    Before you buy Capricorn Metals Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Capricorn Metals Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Chip giant TSMC crosses $1 trillion market cap, riding on the back of Nvidia’s gains

    Visitors taking photofs at a TSMC booth at the 2024 World Semiconductor Congress in Nanjing, China.
    TSMC's stock is benefiting from the wave in artificial intelligence.

    • Shares of upstream chip companies TSMC and ASML have surged on the back of Nvidia's gains.
    • TSMC's market cap briefly crossed $1 trillion on Monday.
    • The stock price of ASML — Europe's third-most valuable company — crossed 1,000 euros apiece.

    Tech giant Nvidia has been riding the artificial intelligence wave that made it one of the world's most valuable companies.

    Now, Nvidia's suppliers and upstream partners are riding on the hype, too.

    Taiwan Semiconductor Manufacturing Company, or TSMC, ADR shares on the New York Stock Exchange briefly crossed the $1 trillion valuation mark on Monday after gaining as much as 4.8%. The stock is up nearly 80% this year to date.

    TSMC's shares on the Taiwan Stock Exchange were 0.5% higher at 1,040 New Taiwan Dollars apiece, or $32.26 apiece, at 10:55 a.m. local time on Tuesday.

    TSMC's stock surge on Monday came after Morgan Stanley said it expects the chip giant to hike full-year sales estimates next Thursday when it announces second-quarter earnings.

    TSMC produces, by some estimates, 90% of the world's most advanced processor chips and is the sole supplier of key advanced chips to Nvidia and Apple, among others.

    "Our latest supply chain checks indicate that TSMC is delivering a message that leading-edge foundry supply could be tight in 2025 and customers may not get sufficient capacity allocation without 'appreciating TSMC's value,'" wrote Morgan Stanley analysts led by Charlie Chan on Sunday.

    The analysts called the strategy "hunger marketing."

    Last month, TSMC CEO C.C. Wei hinted that the company was considering a price hike for its products.

    Meanwhile, Nvidia CEO Jensen Huang has said there's so much demand for his company's chips that he has to allocate them "fairly."

    It's not just TSMC that's reaping the benefits of Nvidia's meteoric rise.

    Dutch company ASML, TSMC's equipment supplier, also got a lift with shares briefly crossing 1,000 euros, or $1,082, apiece for the first time on Monday.

    ASML shares closed 0.5% higher at 997.90 euros apiece on the Amsterdam Stock Exchange on Monday and are 42% higher year to date.

    ASML's stock is now worth 395 billion euros — making it the third-most valuable company in Europe after Danish pharma giant Novo Nordisk and French luxury behemoth LVMH.

    ASML reports second-quarter results on July 17.

    Read the original article on Business Insider
  • Biden’s doctor says 8 White House visits by Parkinson’s expert were for routine military staff neurology clinics

    Joe Biden.
    President Joe Biden.

    • The New York Times reported that an expert on Parkinson's disease regularly visited the White House.
    • In a Monday letter, Joe Biden's physician said the expert's visits weren't for the president.
    • Dr. Kevin Cannard hosted neurology clinics for active-duty White House staff, per Biden's doctor.

    In a letter released late Monday, Joe Biden's physician said the reason a Parkinson's expert visited the White House monthly was to host routine neurology clinics for active-duty staff.

    Kevin O'Connor, Biden's physician, wrote the letter to address reporting by The New York Times about the repeated visits by Dr. Kevin Cannard, a neurologist specializing in movement disorders.

    The Times' report, published Monday amid growing critiques of Biden's age and capacity to run for reelection, relied on visitor logs to track eight visits by Cannard in as many months but did not specify why he'd traveled to the White House so often.

    O'Connor wrote that Cannard "was the neurological specialist that examined President Biden for each of his annual physicals" but stressed that Cannard's monthly visits are not related to the president.

    "Prior to the pandemic, and following its end, he has held regular Neurology Clinics at the White House Medical Clinic in support of the thousands of active-duty members assigned in support of White House operations," O'Connor wrote.

    He added: "Many military personnel experience neurological issues related to their service, and Dr. Cannard regularly visits the WHMC as part of this General Neurology practice."

    O'Connor reiterated that Cannard's findings related to the president's health have been made public following each annual physical, adding that Biden "has not seen a neurologist outside of his annual physical."

    Representatives for the Biden administration did not immediately respond to a request for comment from Business Insider.

    Read the original article on Business Insider
  • Nicolas Cage says he’s ‘terrified’ of AI: ‘They’re just going to steal my body and do whatever they want with it’

    American actor Nicolas Cage at Cannes Film Festival 2024. The Surfer Photocall. Cannes (Francia), May 17th, 2024
    Nicolas Cage is not a fan of AI.

    • Nicolas Cage is voicing his concerns about the use of artificial intelligence in Hollywood.
    • "I mean, what are you going to do with my body and my face when I'm dead?" Cage told The New Yorker.
    • Cage's comments come amid growing concerns over the impact AI has on jobs across various industries.

    Nicolas Cage, 60, is speaking up against the use of artificial intelligence in Hollywood.

    In an interview with The New Yorker published on Monday, Cage voiced his concerns about having his likeness manipulated by AI after sharing that he was going to "get a scan done" for a show and a movie he was working on.

    "Well, they have to put me in a computer and match my eye color and change — I don't know. They're just going to steal my body and do whatever they want with it via digital AI," Cage told The New Yorker. "God, I hope not AI. I'm terrified of that. I've been very vocal about it."

    He went on to share his discomfort with the direction that creative industries are heading toward.

    "And it makes me wonder, you know, where will the truth of the artists end up? Is it going to be replaced? Is it going to be transmogrified? Where's the heartbeat going to be?" Cage said.

    What's more concerning is that studios can have control over his likeness even after he dies, he added.

    "I mean, what are you going to do with my body and my face when I'm dead? I don't want you to do anything with it!" he said.

    The "National Treasure" actor is no stranger to having his likeness manipulated for a film.

    In November 2023, the actor told Yahoo Entertainment that his Superman cameo in "The Flash" was different from what he had filmed.

    "First and foremost, I was on set," Cage said. "What I was supposed to do was literally just be standing in an alternate dimension, if you will, and witnessing the destruction of the universe."

    But that wasn't the scene he saw in the final movie.

    "When I went to the picture, it was me fighting a giant spider. I did not do that. That was not what I did," Cage said.

    The actor said he wasn't aware of what had happened, although he doesn't think it was AI.

    But then he offered his thoughts on AI: "AI is a nightmare to me. It's inhumane. You can't get more inhumane than artificial intelligence."

    The use of AI in Hollywood has been a controversial topic in recent years and was a key issue of contention during the 2023 SAG-AFTRA strike, which lasted 118 days.

    Cage isn't the only actor who has spoken up against the use of AI in Hollywood.

    In September 2023, Sean Penn argued that studio execs who want to create AI versions of him should be willing to let him do the same to their daughters.

    "So you want my scans and voice data and all that. OK, here's what I think is fair: I want your daughter's, because I want to create a virtual replica of her and invite my friends over to do whatever we want in a virtual party right now. Would you please look at the camera and tell me you think that's cool?" Penn told Variety.

    And not just the acting industry is up in arms over AI replacing jobs.

    A 2023 Goldman Sachs report found that generative AI could lead to "significant disruption" in the labor market and affect around 300 million full-time jobs globally. The study also found that white-collar workers, particularly US legal workers and administrative staff, are most likely to be affected by new AI tools.

    A representative for Cage did not immediately respond to a request for comment sent outside regular business hours.

    Read the original article on Business Insider
  • Up 327% in a year, the Zip share price just smashed new multi-year highs!

    A young man in a retail shop pays for his purchases using a card

    The Zip Co Ltd (ASX: ZIP) share price is at it again.

    And by ‘it’, I mean notching new multi-year highs.

    Shares in the All Ordinaries Index (ASX: XAO) buy now, pay later (BNPL) stock closed yesterday trading for $1.75. Currently, shares are changing hands for $1.76, up 0.7%.

    As you can see on the chart below, this marks a new two-plus year high for the company.

    In fact, you have to go all the way back to February 2022 to find the Zip share price trading at higher levels.

    With another day in the green today, the Zip share price is now up 327% since this time last year. To put that in some perspective, that’s enough to turn a $5,000 investment into $21,350 in just 12 months!

    What’s been driving the Zip share price higher?

    While there’s still a long, long way to go for the Zip share price to potentially reset the $12.35 a share the BNPL stock was trading for on 19 February 2021, the company has clearly turned a corner over the past nine months.

    Part of that comes amid a change in management and strategy, shifting away from an uncompromising growth strategy to one focused on returning the company to profitability. That strategy is proving successful to date, with Zip’s losses continuing to narrow amid rising revenues.

    The company’s most recent quarterly results, Q3 FY 2024, came out on 16 April.

    Highlights included a 14.6% year on year increase in total transaction volumes (TTV). TTV came in at $2.4 billion for the three months.

    While the company’s Australian business hit some headwinds, its Americas business grew strongly, with TTV in the Americas up by 43.6% from Q3 FY 2023.

    And with Apple Inc (NASDAQ: AAPL) announcing in June that it was pulling its United States BNPL service, Apple Pay Later, investors may be optimistic about Zip’s American growth prospects in the year ahead.

    Then there are interest rates.

    BNPL stocks have proven highly sensitive to a higher rate environment, as witnessed by the huge sell-down in the Zip share price when global rates first bottomed and then began to rise from their historic lows in 2022.

    While Aussies may be waiting until 2025 for the first interest rate cut from the Reserve Bank of Australia, markets are increasingly pricing in at least one rate cut from the US Federal Reserve in 2024.

    Any easing by the Fed and other global central banks should come as welcome news to many companies, particularly those in the BNPL space. And it could help the Zip share price continue to outperform.

    The post Up 327% in a year, the Zip share price just smashed new multi-year highs! appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Zip Co right now?

    Before you buy Zip Co shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Zip Co wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Apple and Zip Co. The Motley Fool Australia has recommended Apple. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Are ASX 200 bank shares too expensive to buy right now?

    Man sitting in front of a laptop and analysing an earnings report.

    ASX 200 bank shares have enjoyed robust shareholder returns ranging from 30% to 45% over the past year.

    Commonwealth Bank of Australia (ASX: CBA), Westpac Banking Corp (ASX: WBC) and National Australia Bank Ltd (ASX: NAB) all notched respective gains following a strong show of earnings. Meanwhile, ANZ Group Holdings Ltd (ASX: ANZ) had a similar run.

    Despite this, the big four banks may not have much room to grow into their currently elevated share prices, according to Macquarie analysts.

    And the fact of the matter is the banking majors are all trading at or near six-month highs. So, is now a good time to buy ASX 200 bank shares? Here’s a closer look.

    Macquarie weary on ASX 200 bank growth

    Macquarie analysts caution that ASX 200 bank shares may struggle to grow into their elevated multiples over the next few years.

    According to The Australian, Macquarie says visibility for the sector is low as pressures on earnings mount. According to the reporting, the firm said:

    Looking forward, we do not see a clear path for underlying profitability to improve meaningfully from a top-down and divisional bottom-up perspective.

    We note that banks’ current returns are broadly in the middle of their 10-year average ranges. As a result, we see limited scope for banks to grow into their elevated multiples

    The broker notes that, despite each of the banks delivering double-digit total shareholder returns over the past year, their earnings have declined, while multiples have expanded “to a 15-30% relative premium [in price-to-earnings ratio (P/E)] versus five-year historical averages”.

    Macquarie also observes that banks are currently experiencing one of the lowest bad debt periods on record, which may not support an earnings recovery in the medium term.

    In H1 FY24, the banking majors booked a total of $1.21 billion in impairment charges, a 13% decrease from the prior corresponding period.

    Despite this, bank share prices have continued to rise. But further growth from here could be a challenge, Macquarie says:

    While multiple expansions often precede the earnings growth phase, this is an improbable outcome, in our view. Periods where the earnings subsequently lifted to support rallying share prices were generally characterised by normalising credit losses following an impairment cycle

    Banks were strong in FY24

    ASX 200 banks showed strong returns on the charts, and the fundamentals remained robust throughout the year.

    Commonwealth Bank shares were up 27% in FY24 as the company reported half-yearly profits of $13.7 billion. According to my colleague James, growth softened towards the end of the year, with a 1% decline in earnings reported for its Q3 FY24 numbers.

    Westpac shares gained 30% in FY24, driven by general market strength and positive operating results.

    The bank’s half-year results in May showed a 16% decrease in net profit to $3.3 billion, yet investors welcomed the 7.1% increase in the interim dividend to 75 cents per share, alongside a fully franked special dividend of 15 cents per share.

    Meanwhile, NAB shareholders must have been happy, as the bank delivered a massive return in FY24. According to my colleague Sebastian, NAB shares started the year at $26.37 each and closed at $36.23, a capital gain of 37.39%.

    Including dividends, investors enjoyed a total yield of 6.33%, resulting in a 43.7% total gain.

    Foolish takeaway

    ASX 200 bank shares have delivered impressive returns in the past year, but analysts warn that their current valuations may be too high. Remember to conduct your own research and consider any long-term goals before making any investment decisions.

    The post Are ASX 200 bank shares too expensive to buy right now? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Australia And New Zealand Banking Group right now?

    Before you buy Australia And New Zealand Banking Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Australia And New Zealand Banking Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why DroneShield, GenusPlus, Monadelphous, and Telstra shares are roaring higher today

    In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is back on form and charging higher. At the time of writing, the benchmark index is up 0.75% to 7,820.8 points.

    Four ASX shares that are rising more than most today are listed below. Here’s why they are racing higher:

    DroneShield Ltd (ASX: DRO)

    The DroneShield share price is up a further 7% to a new record high of $2.15. This is despite there being no news out of the counter drone technology company on Tuesday. In fact, it has been almost three weeks since there was meaningful news out of the market darling. Nevertheless, investors appear to believe that DroneShield is perfectly positioned to continue its explosive growth thanks to industry tailwinds and some major contract wins. Its shares are now up over 450% since the start of the year.

    GenusPlus Group Ltd (ASX: GNP)

    The GenusPlus share price is up 5% to $2.04. Investors have been buying the national essential power and communications infrastructure provider’s shares after it announced a major program of maintenance and upgrade works for Western Power. Genus will provide distribution and transmission overhead maintenance services across Western Power’s network. The five-year agreement is expected to generate revenue of approximately $50 million in its first year.

    Monadelphous Group Ltd (ASX: MND)

    The Monadelphous share price is up 2% to $12.88. This morning, the engineering company announced that it has been awarded a major long-term maintenance and minor construction services contract. The contract is associated with Shell Australia’s Prelude Floating Liquefied Natural Gas (FLNG) facility. The seven year contract will commence in November when the company’s existing contract with Shell ends. Management believes that “renewing this significant contract demonstrates Monadelphous’ leadership position in the Australian energy maintenance market, both onshore and offshore.”

    Telstra Group Ltd (ASX: TLS)

    The Telstra Group share price is up almost 3% to $3.75. Investors have been buying the telco giant’s shares after it announced an increase to its mobile prices. The changes will see prices on most Telstra mobile plans increase by between $2 to $4 per month. Management notes that these changes aimed to balance cost of living pressures “with its need to continue to invest to manage technology evolution and continued strong customer demand on its mobile network.” Judging by its share price performance, the market appears to believe the company has got it just right with these increases.

    The post Why DroneShield, GenusPlus, Monadelphous, and Telstra shares are roaring higher today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Droneshield Limited right now?

    Before you buy Droneshield Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Droneshield Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and GenusPlus Group. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today

    The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday. In afternoon trade, the benchmark index is up 0.8% to 7,823.6 points.

    Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

    Clinuvel Pharmaceuticals Limited (ASX: CUV)

    The Clinuvel Pharmaceuticals share price is down 6.5% to $14.50. This appears to have been driven by a broker note out of Morgans this morning. According to the note, the broker has downgraded the biopharmaceutical company’s shares to a hold rating with a $16.00 price target. Morgans made the move partly on valuation grounds. It also highlights that there are risks around competition that investors should be considering.

    Mesoblast Ltd (ASX: MSB)

    The Mesoblast share price is down 4.5% to $1.07. This is despite the release of a positive announcement this morning from the biotechnology company. Mesoblast revealed that it has now resubmitted its biologic license application (BLA) for the approval of Ryoncil in the treatment of children with steroid-refractory acute graft-versus-host disease (SR-aGVHD). Management expects an answer from the United States Food & Drug Administration (FDA) in two to six months. But with its shares up almost 300% over the past six months, it seems that some investors aren’t sticking around to find out if it will finally be approved.

    Red Hill Minerals Ltd (ASX: RHI)

    The Red Hill Minerals share price is down 21% to $6.19. This has been driven by the iron ore, gold, and base metals explorer’s shares going ex-dividend this morning for a big payout. Last week, the company announced a $1.50 per share fully franked dividend. This was in response to the receipt of $200 million milestone payment from Mineral Resources Ltd (ASX: MIN) relating to the Onslow Iron Project. Eligible shareholders can now look forward to receiving this dividend next week on 19 July. Based on yesterday’s close price, this payout represents a sizeable 19.2% dividend yield.

    Resimac Group Ltd (ASX: RMC)

    The Resimac share price is down 4% to 83 cents. Investors have been selling this non-bank lender’s shares today after it announced the sudden exit of its CEO. According to the release, Scott McWilliam has resigned from his employment with Resimac after 21 years of service. This includes six years as its CEO and three years as its joint CEO following the merger with Homeloans Limited. Mr McWilliam will take a period of leave before his employment contract ends on 1 September 2024.

    The post Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Clinuvel Pharmaceuticals right now?

    Before you buy Clinuvel Pharmaceuticals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Clinuvel Pharmaceuticals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Meet the motorcycle-riding, dog-loving ‘Bachelorette’ star Sam M., who just nabbed Jenn’s first impression rose

    "The Bachelorette" season 21 contestant Sam M.
    "The Bachelorette" season 21 contestant Sam M.

    • Season 21 of "The Bachelorette" starring Jenn Tran premiered Monday.
    • On night one, Jenn gave the first impression rose to Sam McKinney.
    • Sam is a general contractor from Myrtle Beach, South Carolina. 

    Warning: Spoilers ahead for the season 21 premiere of "The Bachelorette."

    Jenn Tran's season of "The Bachelorette" is just getting started, and she's already developing connections with the men vying for her heart.

    Sam McKinney, one of the 25 guys competing on season 21, quickly hit it off with Jenn after stepping out of the limo. At the end of the night, Jenn gave him the first impression rose.

    Here's everything to know about Sam M. and his growing connection with Jenn.

    Sam M. is a general contractor from Myrtle Beach, South Carolina

    Sam, 27, is one of five children. He attended Socastee High School, where he was on the football, baseball, and wrestling teams. After graduating, he attended Wofford College.

    According to his bio on ABC's website, outside his current work as a contractor, Sam enjoys "riding motorcycles, golfing, and watching 'Sons of Anarchy.'" Based on his Instagram profile, he seems to be a dog lover, too.

    Prior to "The Bachelorette," Sam was single for almost a year.

    During the season premiere, he explained that his fiancé, who he had known since middle school, cheated on him and there was "no repairing that relationship."

    "That was definitely the biggest heartbreak I've ever experienced," he said.

    Despite this, Sam is still determined to fulfill his dream of being a husband and father.

    Jenn gave Sam her first impression rose after feeling an 'undeniable connection'

    "The Bachelorette" star Jenn Tran and contestant Sam M. on the season 21 premiere.
    "The Bachelorette" star Jenn Tran and contestant Sam M. on the season 21 premiere.

    Sam doesn't have an over-the-top limo entrance, but Jenn is immediately taken by his looks and "Southern charm."

    During their one-on-one conversation, the first of the evening, Jenn and Sam bond over their similar approaches to dating; they both value being intentional and vulnerable in relationships.

    "Sam M. makes me feel excited," Jenn says. There's an undeniable connection and I don't know what it is. I'm looking at how hot he is and I definitely want to kiss him, but it just doesn't feel right in that moment."

    After chatting with the other men, Jenn decides to give her first impression rose to Sam, whom she says she couldn't stop thinking about all night. They share a passionate kiss, making Jenn even more confident in her choice to give him the rose.

    "I feel like I'm floating on cloud nine," she says. "This kiss is feral. The kiss was really, really good. I feel like I made the right decision in waiting because this was the kiss that had been building up all night. Definitely worth the wait."

    New episodes of season 21 of "The Bachelorette" premiere on Mondays on ABC and stream the next day on Hulu.

    Read the original article on Business Insider
  • 4 reasons to buy Woodside shares today

    An oil worker assesses productivity at an oil rig as ASX 200 energy shares continue to rise

    Woodside Energy Group Ltd (ASX: WDS) shares are in the green today.

    Shares in the S&P/ASX 200 Index (ASX: XJO) oil and gas stock closed yesterday trading for $28.74. In morning trade on Tuesday, shares are changing hands for $28.88 apiece, up 0.5%.

    For some context the ASX 200 is up 0.7% at this same time.

    That’s today’s price action for you.

    Now, here are four reasons BW Equities’ Tom Bleakley is optimistic on the outlook for Woodside shares (courtesy of The Bull).

    Why Woodside shares could run hot into 2025

    The first reason to buy Woodside shares is the strong outlook for global oil demand and prices.

    Bleakley, who has a ‘buy’ rating on the ASX 200 oil and gas company, noted that “This energy giant has been benefiting from increasing crude oil prices.”

    He added, “Electric vehicle sales growth has been slower than expected in the US.”

    Indeed, while EV adoption is still growing in the world’s biggest economy, the growth rate has slowed significantly. That portends a greater reliance, for longer, on petrol cars. A reliance that certainly remains the case across the fast-growing African continent.

    At the time of writing, Brent crude is trading for US$86 per barrel, up from $78 per barrel on 4 June. And with global crude demand forecast to increase to new record highs in 2025, 4 June could well mark the lows for the year ahead.

    Which brings us to the second reason to buy Woodside shares now, some extra passive income.

    “The company was recently trading on an appealing dividend yield above 7%,” Bleakley said.

    Over the past 12 months, Woodside has paid out a total of $2.16 per share in fully franked dividends. At the current share price, that equates to a fully franked trailing yield of 7.5%.

    Moving on to the third reason to buy the ASX 200 oil and gas company today, Bleakley noted that “Woodside recently announced it had achieved first oil from the Sangomar field in Senegal.”

    Woodside reported that first oil on 11 June.

    As we noted about the project growth potential on the day:

    The deepwater Sangomar Field Development Phase 1 project includes a stand-alone floating production storage and offloading (FPSO) facility. The nameplate capacity stands at 100,000 barrels per day. The project includes subsea infrastructure designed to allow further development phases.

    Rounding off the list, the fourth reason to buy Woodside stock today is that shares are in an uptrend yet remain well below their recent highs.

    “Woodside shares have risen from $26.97 on June 24 to trade at $29.22 on July 4. The shares are still trading well below $39 achieved in August 2023,” Bleakley said.

    Those August 2023 levels represent a potential upside of 35% from current prices.

    The post 4 reasons to buy Woodside shares today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woodside Petroleum Ltd right now?

    Before you buy Woodside Petroleum Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woodside Petroleum Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.